INTRALUMINAL THERAPEUTICS
IntraLuminal Therapeutics is a medical device company provides products for the interventional cardiologist and radiologist to cross and recanalize totally occluded arteries. The companyโs platform technology has therapeutic application for various cardiovascular, surgical, neurological, carotid, and menโs and womenโs health procedures. IntraLuminal Therapeutics was founded in 1997 and is based in Carlsbad, California.
INTRALUMINAL THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
1997-01-01
Address:
Carlsbad, California, United States
Country:
United States
Total Employee:
101+
Status:
Active
Total Funding:
20 M USD
Similar Organizations
Azaya Therapeutics
Azaya Therapeutics is a biotechnology company developing therapies for cancer and other serious medical conditions.
ImaRX Therapeutics
ImaRX Therapeutics is a biopharmaceutical company that develops and distributes stroke and vascular disorder therapies.
Palisade Therapeutics
Palisade Therapeutics develops therapeutics-based products for the treatment of neurological diseases.
Investors List
Geoffrey Hartzler
Geoffrey Hartzler investment in Venture Round - IntraLuminal Therapeutics
Covera Ventures
Covera Ventures investment in Venture Round - IntraLuminal Therapeutics
CDP Capital Technologies
CDP Capital Technologies investment in Venture Round - IntraLuminal Therapeutics
Greenspring Associates
Greenspring Associates investment in Venture Round - IntraLuminal Therapeutics
GE Capital
GE Capital investment in Venture Round - IntraLuminal Therapeutics
MPM Capital
MPM Capital investment in Venture Round - IntraLuminal Therapeutics
More informations about "IntraLuminal Therapeutics"
IntraLuminal Therapeutics - Funding, Financials, Valuation
IntraLuminal Therapeutics provides products for interventional cardiologists and radiologists to recanalize totally occluded arteries. Search Crunchbase. ... How much funding has this โฆSee details»
IntraLuminal Therapeutics acquired by Kensey Nash Corporation
IntraLuminal Therapeutics IntraLuminal Therapeutics provides products for interventional cardiologists and radiologists to recanalize totally occluded arteries. Acquiring Organization: โฆSee details»
IntraLuminal Therapeutics, Inc.: Drug pipelines, Patents, Clinical ...
Jul 5, 2023 Explore IntraLuminal Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
IntraLuminal Therapeutics - Overview, News & Similar companies ...
IntraLuminal Therapeutics develops novel forward-looking guidance systems addressing the last frontier of angioplasty by safely crossing and recana lizing total occlusions. The Safe-Cross® โฆSee details»
IntraLuminal Therapeutics Stock Price, Funding, Valuation, โฆ
May 11, 2006 See IntraLuminal Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on IntraLuminal Therapeutics's post-money valuation โฆSee details»
IntraLuminal Therapeutics Inc. - HBW Insight
IntraLuminal Therapeutics Inc. 01 Mar 1999. IntraLuminal Therapeutics is developing a new guidance system designed to help interventional cardiologists safely cross total occlusions. โฆSee details»
IntraLuminal Therapeutics :: Medtech Insight
Nov 16, 1998 Firm unveils Safe-Steer chronic total occlusions wire/catheter system at AHA conference in Dallas, Texas. The Carlsbad, California-based start-up company hopes to build โฆSee details»
Initial experience and safety in the treatment of chronic total ...
Sep 15, 2003 Ability to cross the lesion with a guidewire is the main determinant of success in 80% of cases.2,3 To facilitate guidewire crossing of CTOs, a new guidance system, the Safe โฆSee details»
Utility of the Safe-Cross-guided radiofrequency total occlusion ...
Oct 1, 2004 The Safe-Cross radiofrequency guidewire (IntraLuminal Therapeutics, Carlsbad, California) combines 3 capabilities: (1) steerability of a conventional 0.014-in intermediate โฆSee details»
Utility of the Safe-Crossโguided radiofrequency total occlusion ...
Oct 1, 2004 The Safe-Cross radiofrequency guidewire (IntraLuminal Therapeutics, Carlsbad, California) combines 3 capabilities: (1) steerability of a conventional 0.014-in intermediate โฆSee details»
IntraLuminal Therapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. IntraLuminal Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Patents and Trademarks by IPqwery. ...See details»
Intraplaque therapies for facilitating percutaneous recanalization โฆ
Occur as part of the organization phase in CTO in which thrombus is replaced by fibrous tissue. These microvessels generally range in size from 100 ฮผm to 200 ฮผm but can sometimes be as โฆSee details»
Lumen-oriented versus wall-oriented treatment strategies for ...
Nov 19, 2021 The 641 studies included were reviewed and categorized as primarily a lumen-oriented or wall-oriented treatment strategy published from 1963 to 2021. Lumen-oriented โฆSee details»
Intraluminal Thrombus and Outcomes of Patients With Acute โฆ
Mar 4, 2021 Background and Purpose: Intraluminal thrombus (ILT) is an emerging imaging marker in acute ischemic stroke. We aimed to investigate the association of ILT with outcomes โฆSee details»
Intraluminal Thrombus of the Extracranial Cerebral Arteries in โฆ
Jan 3, 2024 Introduction. Intraluminal thrombus (ILT) is an infrequent finding that can lead to an acute or recurrent ischemic stroke. It is defined as an elongated thrombus attached to the โฆSee details»
IntraLuminal Therapeutics - Crunchbase
Azaya Therapeutics is a biotechnology company developing therapies for cancer and other serious medical conditions. IntraLuminal Therapeutics and Azaya Therapeutics share similar โฆSee details»
Intraluminal Thrombi in the Cervico-Cephalic Arteries:
Dec 31, 2018 Background and Purposeโ Intraluminal thrombus (ILT) is an uncommon finding among patients with ischemic stroke. We report clinical-imaging manifestations, treatment โฆSee details»
Full article: Intraluminal Thrombus of the Extracranial Cerebral ...
Jan 3, 2024 Intraluminal thrombus (ILT) of the cervical arteries is an uncommon finding that can lead to acute or recurrent ischemic stroke. Currently, antithrombotic therapy in the form of โฆSee details»
Intraluminal Thrombus and Outcomes of Patients With Acute โฆ
Mar 4, 2021 Intraluminal thrombus (ILT), 1 also called intraluminal clot, 2 intraluminal nonocclusive thrombus, 3 or free-floating thrombus, 4 is an uncommon but emerging imaging โฆSee details»